BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 9554527)

  • 1. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV; Gertz MA; Kyle RA
    Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgD multiple myeloma. A report of three cases.
    Martini R; Santini S; Bottari G
    Minerva Med; 1996 Mar; 87(3):109-12. PubMed ID: 8668286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients.
    Gertz MA; Kyle RA; O'Fallon WM
    Arch Intern Med; 1992 Nov; 152(11):2245-50. PubMed ID: 1444684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic criteria of multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary systemic amyloidosis: response and survival in 64 patients.
    Gertz MA; Kyle RA
    Medicine (Baltimore); 1991 Jul; 70(4):246-56. PubMed ID: 2067409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of thirty-four rheumatoid arthritis patients with renal amyloidosis, including twelve given alkylating agents.
    Couverchel L; Maugars Y; Prost A
    Rev Rhum Engl Ed; 1995 Feb; 62(2):79-85. PubMed ID: 7600076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rapid progression of systemic amyloidosis after high-dose corticosteroid therapy in multiple myeloma].
    Kanoh T; Yogo K; Ohnaka T
    Rinsho Ketsueki; 1990 Oct; 31(10):1736-9. PubMed ID: 2255065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgD myeloma with myelofibrosis and amyloidosis.
    Udoji WC; Pemmaraju S
    Arch Pathol Lab Med; 1977 Jan; 101(1):10-3. PubMed ID: 401635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of gastric amyloidosis developing into Bence-Jones type multiple myeloma, treated effectively by cyclo-VAMP chemotherapy].
    Ayabe T; Maekawa I; Ashida T; Taruishi M; Shibata Y; Namiki M
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2399-403. PubMed ID: 8259860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma cell leukemia. Study of 10 cases].
    López Guillermo A; Martí JM; Bladé J; Nomdedeu B; Montserrat E; Rozman C
    Sangre (Barc); 1989 Feb; 34(1):28-31. PubMed ID: 2652343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma cell leukemia. Study of 6 patients].
    Las Heras G; Ribera JM; Abella E; Batlle M; Flores A; Millá F; Feliu E
    Sangre (Barc); 1992 Aug; 37(4):255-8. PubMed ID: 1514138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute leukemia and cytogenetic abnormalities complicating melphalan treatment of primary systemic amyloidosis.
    Gertz MA; Kyle RA
    Arch Intern Med; 1990 Mar; 150(3):629-33. PubMed ID: 2310282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma and acute leukemia associated with alkylating agents.
    Kyle RA; Pierre RV; Bayrd ED
    Arch Intern Med; 1975 Jan; 135(1):185-92. PubMed ID: 1053891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloidosis in multiple myeloma or without apparent cause.
    Alexanian R; Fraschini G; Smith L
    Arch Intern Med; 1984 Nov; 144(11):2158-60. PubMed ID: 6437354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of primary amyloidosis with melphalan and prednisone.
    Schwartz RS; Cohen JR; Schrier SL
    Arch Intern Med; 1979 Oct; 139(10):1144-7. PubMed ID: 485747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extramedullary plasmacytomas presenting as mediastinal masses: clinicopathologic study of two cases preceding the onset of multiple myeloma.
    Moran CA; Suster S; Fishback NF; Koss MN
    Mod Pathol; 1995 Apr; 8(3):257-9. PubMed ID: 7617650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple myeloma].
    Kanoh T
    Rinsho Ketsueki; 1989 Aug; 30(8):1212-5. PubMed ID: 2601036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple myeloma after monoclonal gammopathy of uncertain significance. Study of 10 patients].
    Salgado C; Bladé J; López-Guillermo A; Cervantes F; Montserrat E; Rozman C
    Sangre (Barc); 1993 Oct; 38(5):371-4. PubMed ID: 8140498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2 cases of multiple myeloma with osteosclerosis].
    Felder M; Keiser G; Wirth W
    Schweiz Med Wochenschr; 1979 Nov; 109(44):1713-9. PubMed ID: 524105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating intravenous courses of melphalan and peptichemio in high-risk multiple myeloma (preliminary results).
    Franchi F; Seminara P; Rossi Fanelli F
    Anticancer Res; 1986; 6(2):297-8. PubMed ID: 3707066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.